iPierian Company
iPierian is a drug discovery platform that develops therapies for neurodegenerative diseases such as SMA, ALS, and Parkinson's.
Technology:
Drug Delivery
Industry:
PharmTech
Headquarters:
South San Francisco, California, United States
Founded Date:
2007
Employees Number:
11-50
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Register and Claim Ownership